Phase I Clinical Trial: Evaluating the Efficacy, Safety, and Patient Satisfaction of Platelet-Rich Plasma (PRP) Injections and Microneedling for Androgenetic Alopecia Treatment

I期临床试验:评估富血小板血浆(PRP)注射联合微针疗法治疗雄激素性脱发的疗效、安全性和患者满意度

阅读:1

Abstract

INTRODUCTION: Platelet-rich plasma (PRP) has been widely utilized in dermatological treatments, leading to the development of various administration methods. This study aims to evaluate and compare the effectiveness of PRP injections and microneedling techniques for treating androgenetic alopecia (AGA) in clinical practice. MATERIALS AND METHODS: A total of 40 participants diagnosed with AGA, aged between 18 and 50 years, were randomly assigned to receive either PRP injections or microneedling treatments. Each patient underwent two treatment sessions, with a 1-month interval between them. Hair density and thickness measurements were performed using TrichoScan before treatment and 2 months after the final session. Statistical analysis was conducted using SPSS software. RESULTS: Among the participants, 28.57% were male and 71.43% were female, with an average age of 40.2 years (±7.7). In the PRP injection group, hair count increased by approximately 62.4% (from 17.40 ± 2.074 to 28.26 ± 6.229), and hair thickness improved by 58.6% (from 58.0 ± 25.01 to 92.0 ± 16.31). In the microneedling group, hair count increased by 88.4% (from 14.71 ± 3.988 to 27.71 ± 4.499), while hair thickness improved by 51.3% (from 49.0 ± 11.30 to 74.14 ± 22.42). Although both groups showed statistically significant improvements (p < 0.05), the intergroup differences in hair count and thickness were not statistically significant (p > 0.05). CONCLUSION: The findings of this study confirm PRP as a viable treatment option for AGA. Both injection and microneedling methods provided therapeutic benefits. Additionally, microneedling appeared to enhance patient satisfaction and treatment tolerance.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。